P167 The variation of faecal calprotectin level within the first months after bowel resection is predictive of endoscopic postoperative recurrence in patients with Crohn’s disease
M. Boube1, D. Laharie2, S. Nancey3, X. Hébuterne4, M. Fumery5, B. Pariente6, X. Roblin7, L. Peyrin-Biroulet8, M. Reymond1, C. Allimant1, R. Minet-Quinard9, B. Pereira1, G. Bommelaer1, A. Buisson*1
1University Hospital Estaing, IBD Unit, Clermont-Ferrand, France, 2CHU Bordeaux, Bordeaux, France, 3HCL Lyon-Sud, Lyon, France, 4CHU Nice, Nice, France, 5CHU Amiens, Amiens, France, 6CHU Lille, Lille, France, 7CHU Saint-Etienne, Saint-Etienne, France, 8CHU Nancy, Nancy, France, 9University Hospital Estaing, Biochemistry Lab, Clermont-Ferrand, France
Early detection of postoperative recurrence (POR) remains a major concern in patients with Crohn’s disease (CD).
We aimed to assess the performances of serial faecal calprotectin (Fcal) monitoring within the three first months following ileocolonic resection to predict CD endoscopic POR at 6 months.
In this multi-centre prospective study, CD patients who underwent ileocolonic resection were consecutively enrolled. Stools samples were collected at baseline, at 1 month (M1) and M3 to measure Fcal level. The stools samples were collected in the morning the day before the endoscopy to reduce intraindividual variation, and immediately stored at 4°C. Ileocolonoscopy was performed at M6. Endoscopic POR was defined as Rutgeerts’ index ≥ i2b (central reading).
Overall, 48 patients were included. The main characteristics of these patients are detailed in Table 1.
Among them, 18 patients (36%) presented with endoscopic POR (Rutgeerts score ≥ i2b) 6 months after surgery. We did not observe any significant difference between patients with or without early endoscopic POR (M6), respectively, regarding the level of Fcal at baseline (100 [50–190] vs. 166 [89–312] µg/g;
Fcal variation within the first months after ileocolonic resection is an accurate predictor of early endoscopic POR in CD patients.